GenFleet Therapeutics Repurchases 116,000 H-Shares for HKD 3.19 Million, Lifts Treasury Stock to 988,000 Shares

Bulletin Express

Sep 28

GenFleet Therapeutics (Shanghai) Inc. (GENFLEET-B) disclosed a share buyback executed on 28 September 2026 under its existing repurchase mandate approved on 11 May 2026.

Key transaction details: • Volume and pricing: 116,000 H-shares were repurchased on the Hong Kong Stock Exchange at prices ranging from HKD 26.98 to HKD 27.96, with a volume-weighted average cost of HKD 27.4612 per share. The aggregate consideration amounted to HKD 3.19 million. • Capital structure impact: Issued shares (excluding treasury shares) declined by 0.033% to 350.64 million. Treasury shares increased from 872,000 to 988,000, while total issued shares remained unchanged at 351.63 million. • Mandate utilisation: Cumulative buybacks under the current mandate now total 988,000 shares, representing 0.27% of the 370.37 million shares authorised for repurchase. • Post-buyback restrictions: In line with Hong Kong Listing Rules, GenFleet is subject to a moratorium on new share issues or sales of treasury shares until 28 October 2026.

All repurchases were conducted on-market and confirmed to be in full compliance with Hong Kong Stock Exchange regulations and relevant legal requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1179781909"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1179781909\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1179781909?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-28 18:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1179781909","market":"hk","top_or_hot":-1,"title":"GenFleet Therapeutics Repurchases 116,000 H-Shares for HKD 3.19 Million, Lifts Treasury Stock to 988,000 Shares","media":"Bulletin Express","content":"<p>GenFleet Therapeutics (Shanghai) Inc. (GENFLEET-B) disclosed a share buyback executed on 28 September 2026 under its existing repurchase mandate approved on 11 May 2026.</p>\n<p>Key transaction details:\n• Volume and pricing: 116,000 H-shares were repurchased on the Hong Kong Stock Exchange at prices ranging from HKD 26.98 to HKD 27.96, with a volume-weighted average cost of HKD 27.4612 per share. The aggregate consideration amounted to HKD 3.19 million.  \n• Capital structure impact: Issued shares (excluding treasury shares) declined by 0.033% to 350.64 million. Treasury shares increased from 872,000 to 988,000, while total issued shares remained unchanged at 351.63 million.  \n• Mandate utilisation: Cumulative buybacks under the current mandate now total 988,000 shares, representing 0.27% of the 370.37 million shares authorised for repurchase.  \n• Post-buyback restrictions: In line with Hong Kong Listing Rules, GenFleet is subject to a moratorium on new share issues or sales of treasury shares until 28 October 2026.</p>\n<p>All repurchases were conducted on-market and confirmed to be in full compliance with Hong Kong Stock Exchange regulations and relevant legal requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GenFleet Therapeutics Repurchases 116,000 H-Shares for HKD 3.19 Million, Lifts Treasury Stock to 988,000 Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGenFleet Therapeutics Repurchases 116,000 H-Shares for HKD 3.19 Million, Lifts Treasury Stock to 988,000 Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-09-28 18:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>GenFleet Therapeutics (Shanghai) Inc. (GENFLEET-B) disclosed a share buyback executed on 28 September 2026 under its existing repurchase mandate approved on 11 May 2026.</p>\n<p>Key transaction details:\n• Volume and pricing: 116,000 H-shares were repurchased on the Hong Kong Stock Exchange at prices ranging from HKD 26.98 to HKD 27.96, with a volume-weighted average cost of HKD 27.4612 per share. The aggregate consideration amounted to HKD 3.19 million.  \n• Capital structure impact: Issued shares (excluding treasury shares) declined by 0.033% to 350.64 million. Treasury shares increased from 872,000 to 988,000, while total issued shares remained unchanged at 351.63 million.  \n• Mandate utilisation: Cumulative buybacks under the current mandate now total 988,000 shares, representing 0.27% of the 370.37 million shares authorised for repurchase.  \n• Post-buyback restrictions: In line with Hong Kong Listing Rules, GenFleet is subject to a moratorium on new share issues or sales of treasury shares until 28 October 2026.</p>\n<p>All repurchases were conducted on-market and confirmed to be in full compliance with Hong Kong Stock Exchange regulations and relevant legal requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02595","symbol_name":"劲方医药-B","start_time":0,"source_url":"","article_id":"1179781909","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1179781909","pubTimestamp":1790589671,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"GenFleet Therapeutics (Shanghai) Inc. (GENFLEET-B) disclosed a share buyback executed on 28 September 2026 under its existing repurchase mandate approved on 11 May 2026. Key transaction details: •...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02595":"劲方医药-B"},"translate_title":"GenFleet Therapeutics以319万港元回购11.6万股H股，库存股增至98.8万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02595":1},"content_text":"GenFleet Therapeutics (Shanghai) Inc. (GENFLEET-B) disclosed a share buyback executed on 28 September 2026 under its existing repurchase mandate approved on 11 May 2026.\nKey transaction details:\n• Volume and pricing: 116,000 H-shares were repurchased on the Hong Kong Stock Exchange at prices ranging from HKD 26.98 to HKD 27.96, with a volume-weighted average cost of HKD 27.4612 per share. The aggregate consideration amounted to HKD 3.19 million.  \n• Capital structure impact: Issued shares (excluding treasury shares) declined by 0.033% to 350.64 million. Treasury shares increased from 872,000 to 988,000, while total issued shares remained unchanged at 351.63 million.  \n• Mandate utilisation: Cumulative buybacks under the current mandate now total 988,000 shares, representing 0.27% of the 370.37 million shares authorised for repurchase.  \n• Post-buyback restrictions: In line with Hong Kong Listing Rules, GenFleet is subject to a moratorium on new share issues or sales of treasury shares until 28 October 2026.\nAll repurchases were conducted on-market and confirmed to be in full compliance with Hong Kong Stock Exchange regulations and relevant legal requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}